先进制造业知识服务平台
国家科技图书文献中心机械分馆  工信部产业技术基础公共服务平台  国家中小企业公共服务示范平台

OA期刊


ISSN1942-0862
刊名Mabs
出版商Taylor & Francis Inc.
urlhttps://www.tandfonline.com/loi/kmab20
机构Taylor & Francis Ltd.



全部

2010 2011 2012 2013 2014 2015
2016 2017 2018 2019 2020 2021
2022 2023 2024 2025

2025, vol.17, no.1 2025, vol.17, no.2 2025, vol.17, no.3 2025, vol.17, no.4

题名作者出版年年卷期
Preclinical development of ozuriftamab vedotin (BA3021), a novel ROR2-specific conditionally active biologic antibody–drug conjugateHwai Wen Chang;Gerhard Frey;Jing Wang;Haizhen Liu;Charles Xing;Jian Chen;William J. Boyle;Jay M. Short;20252025, vol.17, no.4
Recommended nomenclature convention for the NISTCHO cell line and its product monoclonal antibody, cNISTmAbMegan H. Cleveland;Ioannis L. Karageorgos;John P. Marino;Michael J. Tarlov;Katharina S. Yandrofski;Rebecca A. Zangmeister;Zvi Kelman;20252025, vol.17, no.4
Nanoscale warriors against viral invaders: a comprehensive review of Nanobodies as potential antiviral therapeuticsVaishali Verma;Nimisha Sinha;Abhavya Raja;20252025, vol.17, no.4
How to think about designing smart antibodies in the age of genAI: integrating biology, technology, and experienceAndrew Buchanan;Eric Bennett;Rebecca Croasdale-Wood;Andreas Evers;Brian Fennell;Norbert Furtmann;Konrad Krawczyk;Sandeep Kumar;Christopher James Langmead;Melody Shahsavarian;Christine Elaine Tinbergj;20252025, vol.17, no.4
Leveraging multi-modal feature learning for predictions of antibody viscosityKrishna D. B. Anapindi a;Kai Liu;Willie Wang;Yao Yu;Yan He;Edward J. Hsieh;Ying Huang;Daniela Tomazelaa;20252025, vol.17, no.4
Accelerating high-concentration monoclonal antibody development with large-scale viscosity data and ensemble deep learningLateefat A. Kalejaye;Jia-Min Chu;I-En Wu;Bismark Amofah;Amber Lee;Mark Hutchinson;Chacko Chakiath;Andrew Dippel;Gilad Kaplan;Melissa Damschroder;Valentin Stanev;Maryam Pouryahya;Mehdi Boroumand;Jenna Caldwell;Alison Hinton;Madison Kreitz;Mitali Shah;Austin Gallegos;Neil Mody;Pin-Kuang Lai;20252025, vol.17, no.4
Maximizing activity and selectivity of antibody-mediated effector functions using antibody mixturesTiexin Wang;Alec A. Desai;Greg M. Thurber;Peter M. Tessier;20252025, vol.17, no.4
Successful targeting of multidrug-resistant tumors with bispecific antibodiesRaffaella Briante;Qianting Zhai;Suchismita Mohanty;Pingping Zhang;Alissa O’Connor;Hiwot Misker;Willie Wang;Cindy Tan;Mastewal Abuhay;Jessica Morgan;Richard Theolis;Paul Ponath;Robert Arathoon;20252025, vol.17, no.4
The physiological limits of bispecific monoclonal antibody tissue targeting specificityArmin Sepp;Felix Stader;Abdallah Derbalah;Cong Liu;Adriana Zyl;Iain Gardner;Masoud Jamei;20252025, vol.17, no.4